CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions | Total | Common Stock | Additional Paid-in Capital | Retained Earnings |
Beginning balance (in shares) at Dec. 31, 2022 | | 134,715,094 | | |
Beginning balance at Dec. 31, 2022 | $ 9,124 | $ 1 | $ 5,724 | $ 3,399 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 92,048 | | |
Share-based compensation | 5 | | 5 | |
Issuance of common stock for warrant exercise (in shares) | | 4,654 | | |
Issuance of common stock for warrant exercise | 0 | | | |
Repurchase and retirement of common stock (in shares) | | (792,543) | | |
Repurchase and retirement of common stock | (60) | | | (60) |
Net income (loss) | 1,389 | | | 1,389 |
Dividends on common stock | (175) | | | (175) |
Ending balance (in shares) at Mar. 31, 2023 | | 134,019,253 | | |
Ending balance at Mar. 31, 2023 | 10,283 | $ 1 | 5,729 | 4,553 |
Beginning balance (in shares) at Dec. 31, 2022 | | 134,715,094 | | |
Beginning balance at Dec. 31, 2022 | 9,124 | $ 1 | 5,724 | 3,399 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Repurchase and retirement of common stock (in shares) | | (3,700,000) | | |
Repurchase and retirement of common stock | | $ (305) | | |
Net income (loss) | 1,850 | | | |
Ending balance (in shares) at Sep. 30, 2023 | | 131,182,918 | | |
Ending balance at Sep. 30, 2023 | 10,268 | $ 1 | 5,735 | 4,532 |
Beginning balance (in shares) at Mar. 31, 2023 | | 134,019,253 | | |
Beginning balance at Mar. 31, 2023 | 10,283 | $ 1 | 5,729 | 4,553 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 109,012 | | |
Share-based compensation | 7 | | 7 | |
Issuance of common stock for warrant exercise (in shares) | | 878 | | |
Issuance of common stock for warrant exercise | 0 | | | |
Repurchase and retirement of common stock (in shares) | | (1,444,402) | | |
Repurchase and retirement of common stock | (125) | | (10) | (115) |
Net income (loss) | 391 | | | 391 |
Dividends on common stock | (160) | | | (160) |
Ending balance (in shares) at Jun. 30, 2023 | | 132,684,741 | | |
Ending balance at Jun. 30, 2023 | 10,396 | $ 1 | 5,726 | 4,669 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 5,859 | | |
Share-based compensation | 10 | | 10 | |
Issuance of common stock for warrant exercise (in shares) | | 1,809 | | |
Issuance of common stock for warrant exercise | 0 | | | |
Repurchase and retirement of common stock (in shares) | | (1,509,491) | | |
Repurchase and retirement of common stock | (131) | | (1) | (130) |
Net income (loss) | 70 | | | 70 |
Dividends on common stock | (77) | | | (77) |
Ending balance (in shares) at Sep. 30, 2023 | | 131,182,918 | | |
Ending balance at Sep. 30, 2023 | 10,268 | $ 1 | 5,735 | 4,532 |
Beginning balance (in shares) at Dec. 31, 2023 | | 130,789,936 | | |
Beginning balance at Dec. 31, 2023 | 10,729 | $ 1 | 5,754 | 4,974 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 168,538 | | |
Share-based compensation | 4 | | 4 | |
Issuance of common stock for warrant exercise (in shares) | | 201 | | |
Issuance of common stock for warrant exercise | 0 | | | |
Net income (loss) | 26 | | | 26 |
Dividends on common stock | (77) | | | (77) |
Ending balance (in shares) at Mar. 31, 2024 | | 130,958,675 | | |
Ending balance at Mar. 31, 2024 | 10,682 | $ 1 | 5,758 | 4,923 |
Beginning balance (in shares) at Dec. 31, 2023 | | 130,789,936 | | |
Beginning balance at Dec. 31, 2023 | 10,729 | $ 1 | 5,754 | 4,974 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Net income (loss) | (315) | | | |
Ending balance (in shares) at Sep. 30, 2024 | | 135,107,576 | | |
Ending balance at Sep. 30, 2024 | 10,188 | $ 1 | 5,778 | 4,409 |
Beginning balance (in shares) at Mar. 31, 2024 | | 130,958,675 | | |
Beginning balance at Mar. 31, 2024 | 10,682 | $ 1 | 5,758 | 4,923 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 264,072 | | |
Share-based compensation | 9 | | 9 | |
Issuance of common stock for warrant exercise (in shares) | | 29,360 | | |
Issuance of common stock for warrant exercise | 1 | | 1 | |
Net income (loss) | (227) | | | (227) |
Dividends on common stock | (95) | | | (95) |
Ending balance (in shares) at Jun. 30, 2024 | | 131,252,107 | | |
Ending balance at Jun. 30, 2024 | 10,370 | $ 1 | 5,768 | 4,601 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | |
Share-based compensation (in shares) | | 27,618 | | |
Share-based compensation | 10 | | 10 | |
Issuance of common stock for warrant exercise (in shares) | | 3,827,851 | | |
Issuance of common stock for warrant exercise | 0 | | 0 | |
Net income (loss) | (114) | | | (114) |
Dividends on common stock | (78) | | | (78) |
Ending balance (in shares) at Sep. 30, 2024 | | 135,107,576 | | |
Ending balance at Sep. 30, 2024 | $ 10,188 | $ 1 | $ 5,778 | $ 4,409 |